The heart and COVID-19 in the first year of the pandemic: from injury to possible sequelae
DOI:
https://doi.org/10.33448/rsd-v11i9.31428Keywords:
Injury mechanism; Cardiac sequelae; COVID-19; Myocardial injury.Abstract
Objective: Analyze what is understood as causes for myocardial injuries in those affected by SARS-CoV-2, investigating how much this occurrence has the capacity to impact in mortality and ascertain whether this cardiac injury has the potential to generate sequelae. Methodology: This systematic review was conducted according to the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-analyzes). Inclusion criteria included studies that analyze the causes, manifestations, and consequences of the interaction between COVID-19 and myocardium, published in the year 2020 and from January to March 2021 in the bibliographic databases Science Direct, LILACS, MEDLINE, Scielo and PUBMED. Results: After removing duplicates and screening abstracts, 22 articles were potentially eligible for inclusion in this review. After analyzing the texts in full, 16 were included in the research. Six are literature reviews, seven are retrospective studies, one is a case report, one is an experimental study and one is an observational study. Conclusions: Cardiac biomarkers provide fundamental data on the outcome of the disease, mainly because they are able to predict the risk of complications or death. Little is known to date as to whether those recovered from COVID-19 who have had myocardial damage will have relevant cardiac dysfunctions in the long run. More time and more research on the topic its needed.
References
Atri, D., Siddiqi, H.K., Lang, J. P., Nauffal, V., Morrow, D. A., & Bohula, E. A. (2020). COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies, JACC: Basic to Translational Science, 5(5), 518-536. https://doi.org/10.1016/j.jacbts.2020.04.002
Bardají, A., Carrasquer, A., Sánchez-Giménez, R., Lal-Trehan, N., Del-Moral-Ronda, V., Peiró, O. M., Bonet, G., Castilho, G., Fort-Gallifa, I., Benavent, C., Recio, G., Gutiérrez, C., Villavicencio, C., Auguet, T., & Boqué, C. (2020). Implicaciones pronósticas del daño miocárdico en pacientes con y sin diagnóstico confirmado de COVID-19 atendidos en un hospital universitario. Portal Regional da BVS [Internet]. https://pesquisa.bvsalud.org/portal/resource/pt/mdl-32921872
Calvo-Fernández, A., Izquierdo, A., Subirana, I., Farré, N., Vila, J., Durán, X., Gárcia-Guimaraes, M., Valdivielso, S., Cabero, P., Soler, C., García-Ribas, C., Rodríguez, C., Llagostera, M., Mojón, D., Vicente, M., Solé-González, E., Sánchez-Carpintero, A., Tevar, C., Marrugat, J., & Vaquerizo, B. (2020) Marcadores de daño miocárdico en la predicción del pronóstico a corto plazo de los pacientes con COVID-19. Portal Regional da BVS [Internet]. https://pesquisa.bvsalud.org/portal/resource/pt/mdl-33262553
Cevik, M., Bamford, C.G.G., & Ho, A. (2020). COVID-19 pandemic-a focused review for clinicians. Clin Microbiol Infect, 26 (7), 842-847. https://doi.gov/10.1016/j.cmi.2020.04.023
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., Wang, T., Guo, W., Chen, J., Ding, C., Zhang, X., Huang, J., Han, M., Li, S., Luo, X., Zhao, J., & Ning Q. (2020). Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ, 26, 368: m1091. https://doi.gov/10.1136/bmj.m1091
García, L.F. (2020). Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Front Immunol., 16(11),1441. https://doi.org/10.3389/fimmu.2020.01441
Gauchotte, G., Venard, V., Segondy, M., Cadoz, C., Esposito-Fava, A., Barraud, D., & Louis, G. (2021). SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study. Int J Legal Med, 135: 577–581. https://doi.org/10.1007/s00414-020-02500-z
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol., 5(7), 811-818. https://doi.gov/10.1001/jamacardio.2020.1017
Huang, L., Zhao, P., Tang, D., Zhu, T., Han, R., Zhan, C., Liu, W., Zeng, H., Tao, Q., & Xia, L. (2020) Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging, JACC: Cardiovascular Imaging, 13(11), 2330-2339. https://doi.org/10.1016/j.jcmg.2020.05.004
JOHNS HOPKINS UNIVERSITY E MEDICINE, CORONAVIRUS RESOURCE CENTER. (2021). Covid-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. https://coronavirus.jhu.edu/map.html
JOHNS HOPKINS UNIVERSITY E MEDICINE, CORONAVIRUS RESOURCE CENTER. (2021). Understanding Vaccination Progress: Vaccination rollout across the United States. https://coronavirus.jhu.edu/vaccines/international
Kurz, D. J., & Eberli, F .R. (2020). Cardiovascular aspects of COVID-19. Swiss Med Wkly., 150, w2041. https://doi.org/10.4414/smw.2020.20417
Lala, A., Johnson, K. W., Januzzi, J. L., Russak, A. J., Paranjpe, I., Richter, F., Zhao, S., Somani, S., Vleck, T. V., Vaid, A., Chaudhry, F., De Freitas, J. K., Fayad, Z. A., Pinney, S. P., Levin, M., Charney, A., Bagiella, E., Narula, J., Glicksberg, B. S., … & Fuster V. (2020). Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection, Journal of the American College of Cardiology, 76(5), 533-546. https://doi.org/10.1016/j.jacc.2020.06.007
Mamade, Y., Mendes, I., Balhana, S., Pereira, C. S., Vasconcelos, M. & Moreira, A. P. E. A. (2020). COVID-19 e Doença Cardiovascular: Consequências Diretas e Linhas de Investigação. Medicina Interna, 27 (3): 54-60. https://doi.org/10.24950/R/110/20/3/2020
Martins, J. D. N., Sardinha, D. M., Silva, R. R., Lima, K. V. B. & Lima, L. N. G. C. (2020). As implicações da COVID-19 no sistema cardiovascular: prognóstico e intercorrências. J. Health Biol Sci., 8 (1): 1-9. https://doi.org/10.12662/2317-3206jhbs.v8i1.3355.p1-9.2020
Mitrani, R. D., Dabas, N. & Goldberger, J. J. (2020). COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm, 17(11), 1984-1990. /https://doi.org/10.1016/j.hrthm.2020.06.026
Neto, F., Albuquerque, J., Marcondes-Braga, F. G., Moura, L. Z., Figueiredo, A. M. S., Figueiredo, V. M. S., Mourilhe-Rocha, R. & Mesquita, E. T. (2020) Doença de Coronavírus-19 e o Miocárdio. Arq. Bras. Cardiol., 114 (6). https://doi.org/10.36660/abc.20200373
Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., Penninger, J. M. & Butany, J. (2009, julho). SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest, 39(7), 618-625. https://doi.org/10.1111/j.1365-2362.2009.02153.x
Willi, S., Lüthold, R., Hunt, A., Hänggi, N. V., Sejdiu, D., Scaff, C., Bender, N., Staub, K. & Schlagenhauf, P. (2021) COVID-19 sequelae in adults aged less than 50 years: A systematic review. Travel Medicine and Infectious Disease, 40, 101995. https://doi.org/10.1016/j.tmaid.2021.101995
Wu, Z. & McGoogan, J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 323(13), 1239-1242. https://doi: 10.1001/jama.2020.2648
Xiong, Q., Xu, M., Li, J., Liu, Y., Zhang, J., Xu, Y. & Dong, W. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect., 27(1), 89-95. https://doi:10.1016/j.cmi.2020.09.023
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pedro Trindade Stano; Taís de Lima e Fraga; Marileia Chaves Andrade
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
